Official: Device industry won't see extra burden from Sentinel initiative

05/28/2008 | FDAnews

Device companies do not face extra regulatory requirements under the FDA's recently announced Sentinel initiative, said Thomas Gross, head of the CDRH Division of Postmarket Surveillance. He said the new program, which aims to change the agency's postmarket surveillance system, will not affect existing surveillance tools.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ